GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia
Clinical trial NCT04051996 · TERMINATED
Trial details
- NCT number
- NCT04051996
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-06
- Primary completion
- 2020-06-09
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.